Clearing Gentris' GentriSure Controls, FDA Signals Stance on Valid Reference Controls | GenomeWeb
This article has been updated from a previous version to correct a math error in the last paragraph.
The US Food and Drug Administration’s approval of Gentris’ GentriSure, a line of six genomic human reference controls for cytochrome P450 2D6 genetic testing, signals that the agency feels the quality of reference controls is just as important as validated genetic tests, the company said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.